NASDAQ:DFFN
Delisted

Diffusion Pharmaceuticals Stock News

etoro logo Buy DFFN
*Your capital is at risk
$5.87
+0 (+0%)
At Close: Nov 28, 2023
This IND, which incorporates pre-IND regulatory guidance from the FDA, describes an international clinical development program in the U.S. and EU, newly titled as Phase 1b/2b, testing the Company’s
Out on the Street, it’s full speed ahead. Despite the chaotic events of 2020, the S&P; 500, which is coming off of its best quarter in more than 20 years, is down by only 2% year-to-date. Somewhat r
Britain has adequate supplies of Gilead's remdesivir for emergency use to treat hospitalised COVID-19 patients, England's deputy chief medical officer said on Wednesday, though he warned of potential
Britain has adequate supplies of Gilead's remdesivir for emergency use to treat hospitalised COVID-19 patients, England's deputy chief medical officer said on Wednesday, though he warned of potential
Gilead said this week it had allocated nearly all of its supply of the antiviral to the United States over the next three months, stirring concerns about availability elsewhere, particularly in region
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avid Bioservices
UK emergency remdesivir supplies adequate to treat COVID-19, official says
Equities research analysts expect Tristate Capital Holdings Inc (NASDAQ:TSC) to post sales of $50.02 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for T
CEL-SCI Corporation receives $10 million through warrant exercises.
Here's why this shares of this cannabinoid drug company will keep soaring within the next year.
Both of these biotechs could have big catalysts on the way.
In a report issued on June 24, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Tyme Technologies (TYME
The group’s goal is to create a roadmap that increases the likelihood of interoperability across the Bitcoin SV ecosystem.
Two Sigma Investments LP boosted its position in Tristate Capital Holdings Inc (NASDAQ:TSC) by 629.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securitie
A number of research firms have changed their ratings and price targets for Tristate Capital (NASDAQ: TSC): 6/24/2020 – Tristate Capital was downgraded by analysts at Zacks Investment Research from
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE